Thibault Boutherin
Stock Analyst at Morgan Stanley
(3.53)
# 2,252
Out of 5,036 analysts
143
Total ratings
59.2%
Success rate
6.1%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: SDZ Sandoz Group AG | Reiterated: Sell | CHF 50.00 → CHF 60.00 | CHF 70.74 | -15.18% | 5 | Oct 6, 2026 | |
| NVS Novartis AG | Reiterated: Buy | $170 → $156 | $143.28 | +8.88% | 4 | Oct 6, 2026 | |
| NVO Novo Nordisk | Downgraded: Sell | $40 | $38.26 | +4.55% | 6 | Sep 11, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Buy | CHF 135.00 | CHF 120.02 | +12.48% | 14 | Sep 1, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Hold | CHF 155.00 → CHF 160.00 | CHF 162.60 | -1.60% | 9 | Apr 27, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €40.00 → €53.00 | €43.97 | +20.54% | 5 | Mar 11, 2026 | |
| BME: GRF Grifols, S.A. | Downgraded: Hold | €12.00 → €11.00 | €9.95 | +10.57% | 7 | Mar 10, 2026 | |
| ALVO Alvotech | Reiterated: Buy | $14 → $10 | $5.85 | +70.94% | 4 | Dec 3, 2025 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 650.00 | CHF 577.20 | +12.61% | 10 | Dec 3, 2025 | |
| ETR: MRK Merck KGaA | Reiterated: Hold | €130.00 → €135.00 | €140.15 | -3.67% | 5 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $36 | $36.13 | -0.36% | 11 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €300.00 | €260.00 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €250.00 | €218.80 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 2,100p → 2,400p | 1,646p | n/a | 15 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €12.00 | €2.93 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 | $1.61 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €120.00 | €145.00 | n/a | 18 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $38 | $84.89 | n/a | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | CHF 4.00 → CHF 1.00 | CHF 4.34 | n/a | 11 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $7.50 | n/a | 4 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €11.50 → €11.00 | €10.26 | n/a | 5 | Nov 13, 2023 |
Sandoz Group AG
Oct 6, 2026
Reiterated: Sell
Price Target: CHF 50.00 → CHF 60.00
Current: CHF 70.74
Upside: -15.18%
Novartis AG
Oct 6, 2026
Reiterated: Buy
Price Target: $170 → $156
Current: $143.28
Upside: +8.88%
Novo Nordisk
Sep 11, 2026
Downgraded: Sell
Price Target: $40
Current: $38.26
Upside: +4.55%
Novartis AG
Sep 1, 2026
Reiterated: Buy
Price Target: CHF 135.00
Current: CHF 120.02
Upside: +12.48%
Galderma Group AG
Apr 27, 2026
Reiterated: Hold
Price Target: CHF 155.00 → CHF 160.00
Current: CHF 162.60
Upside: -1.60%
Bayer Aktiengesellschaft
Mar 11, 2026
Reiterated: Buy
Price Target: €40.00 → €53.00
Current: €43.97
Upside: +20.54%
Grifols, S.A.
Mar 10, 2026
Downgraded: Hold
Price Target: €12.00 → €11.00
Current: €9.95
Upside: +10.57%
Alvotech
Dec 3, 2025
Reiterated: Buy
Price Target: $14 → $10
Current: $5.85
Upside: +70.94%
Lonza Group AG
Dec 3, 2025
Reiterated: Buy
Price Target: CHF 650.00
Current: CHF 577.20
Upside: +12.61%
Merck KGaA
Dec 3, 2025
Reiterated: Hold
Price Target: €130.00 → €135.00
Current: €140.15
Upside: -3.67%
Dec 3, 2025
Reiterated: Buy
Price Target: $28 → $36
Current: $36.13
Upside: -0.36%
Apr 22, 2025
Reiterated: Buy
Price Target: €300.00
Current: €260.00
Upside: n/a
Apr 22, 2025
Reiterated: Buy
Price Target: €250.00
Current: €218.80
Upside: n/a
Feb 12, 2025
Reiterated: Hold
Price Target: 2,100p → 2,400p
Current: 1,646p
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: €12.00
Current: €2.93
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: $13
Current: $1.61
Upside: n/a
May 15, 2024
Reiterated: Hold
Price Target: €120.00
Current: €145.00
Upside: n/a
May 8, 2024
Reiterated: Hold
Price Target: $36 → $38
Current: $84.89
Upside: n/a
Apr 3, 2024
Reiterated: Sell
Price Target: CHF 4.00 → CHF 1.00
Current: CHF 4.34
Upside: n/a
Dec 29, 2023
Reiterated: Hold
Price Target: $16
Current: $7.50
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: €11.50 → €11.00
Current: €10.26
Upside: n/a